Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2051-2060

  Hsieh, Tze Chen ^a   Xiong, Wen ^a   Traganos, Frank ^a   Darzynkiewicz, Zbigniew ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Androgen receptor (AR); PC SPES; Prostate LNCaP cells; Prostate specific antigen (PSA)

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; PC SPES; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN METABOLISM; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; DIET SUPPLEMENTATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC REGULATION; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUGS, CHINESE HERBAL; ESTRADIOL; HUMANS; KINETICS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TUMOR CELLS, CULTURED;

EID: 0036332134     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cancer statistics
2. Molecular advances in prostate cancer
3. Prostate cancer: Molecular biology of early progression to androgen independence
4. Prostate cancer: Screening, diagnosis, and management
5. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone
6. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES
7. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC-SPES
8. Induction of apoptosis and down-regulation of bcl-6 in Mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES
9. Survey of USToo members and other prostate cancer patients to evaluate the efficacy and safety of PC-SPES
10. USToo PC-SPES surveys: Review of studies and update of previous survey results
11. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer
12. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
13. Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naïve disease
14. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer
15. Herbal therapy PC-SPES: In vitro effects and evaluation of its efficacy in 69 patients with prostate cancer
16. The effects of phytotherapeutic agents on prostate cancer: An overview of recent clinical trials of PC SPES
17. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: A preliminary investigation on human cell lines and patients
18. PC-SPES, a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
19. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer
20. In vitro mechanism of PC-SPES
21. Chinese herbal mixture PC-SPES in treatment of prostate cancer
22. Apoptotic program is initiated but not completed in LNCaP cells in response to growth in charcoal-stripped media
23. Differential expression and regulation of p53 in human prostatic cells
24. Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis (HGE) pathogen measured by flow and laser scanning cytometry (LSC)
25. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 WAF1/CIP1 and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
26. Suppression of cell growth and induction of apoptosis in the human prostatic JCA-1 cells by the synthetic retinoid, N-(4-hydroxyphenyl) retinamide (4-HPR)
27. Effects of the retinoid 4-HPR on human prostate growth, induction of apoptosis and modulation of androgen receptor (AR) and prostate specific antigen (PSA) expression
28. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models
29. Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line
30. Role of estrogens and SHBG in prostate physiology
31. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor
32. From estrogen to androgen receptor: A new pathway for sex hormones in prostate
33. Prostate cancer
34. Experience with neoadjuvant diethylstilbestrol and radical prostectomy in patients with locally advanced prostate cancer
35. Experience with low-dose estrogen in the treatment of advanced prostate cancer: A personal view